(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -130.00%-583.69K | 120.19%309.61K | 75.03%-281.37K | 65.71%-1.04M | -167.18%-325.56K | 290.63%1.95M | -165.30%-1.53M | 76.75%-1.13M | 92.90%-3.03M | 484.57K |
Net income from continuing operations | 23.66%-4.79M | -388.08%-35.29M | 82.07%-2.92M | 67.16%-48.66M | -83.31%-18.86M | -29.54%-6.27M | 94.45%-7.23M | -507.48%-16.3M | -157.46%-148.16M | ---10.29M |
Operating gains losses | -20.29%7.12M | -76.56%2.25M | -57.24%3.6M | -54.65%31.62M | -62.30%4.68M | 87.88%8.93M | -78.65%9.6M | 10.47%8.41M | 111.94%69.74M | --12.43M |
Asset impairment expenditure | --0 | ---- | ---- | -85.77%19.56M | --19.56M | --0 | ---- | ---- | -6.33%137.48M | --0 |
Remuneration paid in stock | --0 | --0 | --0 | --9.55M | --0 | --0 | --0 | --9.55M | --0 | --0 |
Deferred tax | 39.91%-1.82M | -336.83%-12.84M | 51.55%-1.21M | 75.54%-14.38M | -128.89%-5.92M | 33.99%-3.03M | 93.67%-2.94M | 51.89%-2.49M | -156.77%-58.8M | ---2.59M |
Other non cashItems | -110.39%-241.8K | 1,902.59%16.52M | 237.47%265.17K | -88.44%1.35M | -86.21%126.68K | -36.80%2.33M | -118.80%-916.51K | -102.59%-192.9K | 1,135.78%11.63M | --918.6K |
Change In working capital | 537.70%31.93K | 43.30%-23.58K | 86.47%-13.75K | 99.49%-76.46K | 517.46%74.05K | 60.94%-7.3K | 98.55%-41.58K | 99.16%-101.63K | -22.59%-14.93M | --11.99K |
-Change in receivables | --0 | --0 | --0 | 172.98%33.3K | --0 | --0 | --5.48K | 325.65%27.82K | 98.17%-45.63K | ---12.15K |
-Change in prepaid assets | 172.39%25.17K | 4,008.31%36.56K | -118.20%-75.72K | 50.32%-5.33K | 406.05%63.26K | -378.12%-34.77K | -92.88%890 | 28.04%-34.7K | -100.90%-10.72K | --12.5K |
-Change in payables and accrued expense | -75.40%6.76K | -25.42%-60.14K | 165.40%61.97K | 99.30%-104.43K | -7.27%10.8K | 373.99%27.48K | 98.34%-47.95K | 99.21%-94.75K | -36.70%-14.87M | --11.64K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -130.00%-583.69K | 120.19%309.61K | 75.03%-281.37K | 65.71%-1.04M | -167.18%-325.56K | 290.63%1.95M | -165.30%-1.53M | 76.75%-1.13M | 92.90%-3.03M | --484.57K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Cash from discontinued investing activities | ||||||||||
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | -3.51M | -196K | -2.55M | ||||||
Net common stock issuance | --0 | ---- | ---- | ---3.51M | ---196K | ---2.55M | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | ---- | ---- | ---3.51M | ---196K | ---2.55M | ---- | ---- | --0 | --0 |
Net cash flow | ||||||||||
Beginning cash position | -55.80%866.35K | -86.94%556.74K | -84.45%838.11K | -36.01%5.39M | -72.28%1.36M | -66.93%1.96M | 19.16%4.26M | -36.01%5.39M | -86.93%8.42M | --4.91M |
Current changes in cash | 2.78%-583.69K | 113.44%309.61K | 75.03%-281.37K | -50.05%-4.55M | -207.63%-521.55K | 41.18%-600.37K | -198.08%-2.3M | 76.75%-1.13M | 94.60%-3.03M | --484.57K |
End cash Position | -79.21%282.65K | -55.80%866.35K | -86.94%556.74K | -84.45%838.11K | -84.45%838.11K | -72.28%1.36M | -66.93%1.96M | 19.16%4.26M | -36.01%5.39M | --5.39M |
Free cash from | -130.00%-583.69K | 120.19%309.61K | 75.03%-281.37K | 65.71%-1.04M | -167.18%-325.56K | 290.63%1.95M | -165.30%-1.53M | 76.75%-1.13M | 93.11%-3.03M | --484.57K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data